Identification of heel bone mineral density as a risk factor of Alzheimer’s disease by analyzing large-scale genome-wide association studies datasets
Frontiers in Cell and Developmental Biology · 30.11.2023 · 11
DOI: 10.3389/fcell.2023.1247067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 30.11.2023. Verfasst von Feng Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Introduction
Both low bone mineral density (BMD) and Alzheimer’s disease (AD) commonly co_occur in the older adult. Until now, the association between AD and BMD has been widely reported by observational studies. However, Mendelian randomization (MR) studies did not support the causal association between BMD and AD. We think that the lack of significant causal association between AD and BMD identified by recent MR studies may be caused by small number of potential instrumental variables.
Methods
We conduct a MR study to evaluate the causal effect of heel BMD on the risk of AD using 1,362 genome-wide significant and independent ( p < 5.00E-08) heel BMD genetic variants as the potential instrumental variables, which are identified by a large-scale genome wide association study (GWAS) of heel BMD in 394,929 UK Biobank individuals. Using these 1,362 genome-wide significant and independent heel BMD genetic variants, we extracted their corresponding AD GWAS summary results in IGAP AD GWAS dataset ( n = 63,926) and FinnGen AD GWAS dataset ( n = 377,277). Five methods including inverse-variance weighted meta-analysis (IVW), weighted median, MR-Egger, MR-PRESSO, and MRlap were selected to perform the MR analysis. 951 of these 1,362 genetic variants are available in AD GWAS dataset.
Results
We observed statistically significant causal effect of heel BMD on the risk of AD using IVW in IGAP AD GWAS dataset (OR = 1.048, 95%CI: 1.002–1.095, p = 0.04) and FinnGen AD GWAS dataset (OR = 1.053, 95% CI:1.011–1.098, p = 0.011). Importantly, meta-analysis of IVW estimates from IGAP and FinnGen further supported the causal effect of heel BMD on the risk of AD (OR = 1.051, 95% CI: 1.02–1.083, p = 0.0013).
Discussion
Collectively, our current MR study supports heel BMD to be a risk factor of AD by analyzing the large-scale heel BMD and AD GWAS datasets. The potential mechanisms underlying the association between heel BMD and AD should be further evaluated in future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Orthopedics, Huangshan People's Hospital, Huangshan, China.
Zitieren
APA
Gao, F., Pan, R., Fan, T., Liu, L., & Pan, H. (2023). Identification of heel bone mineral density as a risk factor of Alzheimer’s disease by analyzing large-scale genome-wide association studies datasets. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1247067
Vancouver
Gao F, Pan R, Fan T, Liu L, Pan H. Identification of heel bone mineral density as a risk factor of Alzheimer’s disease by analyzing large-scale genome-wide association studies datasets. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1247067
BibTeX
@article{Gao2023,
author = {Gao, Feng and Pan, Rongrong and Fan, Taixuan and Liu, Lingling and Pan, Haile},
title = {Identification of heel bone mineral density as a risk factor of Alzheimer’s disease by analyzing large-scale genome-wide association studies datasets},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1247067}
}
EUVIMED